While the presence of IL-1β and TNFα is desirable in the TME to augment the activity of cytotoxic T cells, the concurrent increase of IL-10 and IL-23 might raise questions since these cytokines are often associated with the promotion of a tolerogenic environment or in fostering tumor growth and metastases. The gene discussed is TNF; the disease is neoplasm.